LEO INTERNATIONAL PRECISION HEALTH AG (often listed simply as Leo International Precision Health AG) is a small German healthcare-technology company based in the Munich area and traded on the Frankfurt Stock Exchange under the symbol LEOW (or a closely related Frankfurt ticker).

Company overview

Leo International Precision Health AG operates in the healthcare technology sector, focusing on solutions and services linked to precision health and medical technology rather than on traditional pharmaceutical manufacturing. The company’s registered office is in or near Munich (Garching bei München), reflecting its positioning within Germany’s broader life-sciences and tech ecosystem.

Origin and structure

Public information indicates that the current entity evolved from or is associated with SPOBAG AG, an older Munich-based company that previously had limited or no significant operating activities before shifting toward the present precision-health focus. Corporate governance is organized under German stock-corporation (AG) law with a supervisory board structure, as is standard for listed German companies.

Sector and exchange listing

The company is classified within healthcare and technology-related industries, positioning it among smaller listed health-tech firms in Germany. Its shares are traded on the Frankfurt Stock Exchange, with the user-supplied symbol LEOW corresponding to that Frankfurt listing, though data providers may show alternative or parallel Frankfurt codes (for example, SBE or similar).

Important considerations

Leo International Precision Health AG appears to be a relatively small-cap and specialized issuer, so liquidity, available research coverage, and public financial disclosure may be more limited compared with larger Frankfurt-listed healthcare companies. Anyone evaluating the stock should therefore review the latest company filings, official investor relations materials, and current Frankfurt trading data before making investment decisions.